Cefuroxime Sodium Injection, Powder, For Solution
Product Images NDC 25021-119

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefuroxime Sodium (NDC 25021-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cef0c 0008 01

Cef0c 0008 01
FDA Label Image

Cef0c 0008 02

Cef0c 0008 02
FDA Label Image

Cef0c 0008 03

Cef0c 0008 03
FDA Label Image

Cef0c 0008 04

Cef0c 0008 04
This is a product description for a single-dose vial containing 750 mg of cefuroxime activity, for intravenous or intramuscular use. The product is manufactured by SAGENT and labeled FOR INJECTION, USP. Other characters and texts do not provide any useful information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.